James C. Norton, PhD

Practical Research

Clinical Distinctions Between US Nursing Home Residents With Parkinson Disease With and Without Parkinson Disease Psychosis

06/19/2019

Terrence O'Shea , PharmD, BCGP;

James C. Norton , PhD;

Barbara Zarowitz , PharmD, BCPS, BCGP, FCCP, FASCP;

Andrew Shim , PharmD, JD, MAM;

Doral Fredericks , PharmD, MBA;

James C. Norton , PhD;

Barbara Zarowitz , PharmD, BCPS, BCGP, FCCP, FASCP;

James C. Norton , PhD;

Barbara Zarowitz , PharmD, BCPS, BCGP, FCCP, FASCP;

James C. Norton , PhD;

Barbara Zarowitz , PharmD, BCPS, BCGP, FCCP, FASCP;

James C. Norton , PhD;

Terrence O'Shea , PharmD, BCGP;

This retrospective database analysis evaluated the demographic, functional, and clinical characteristics of nursing facility residents (NFR) with Parkinson disease (PD) compared with those with PD psychosis.

This retrospective database...

06/19/2019

Annals of Long-Term Care

Open-Label Study of Pimavanserin Patients With Comorbid Parkinson’s Disease and Depression

Depression occurs in ~50% of Parkinson’s disease (PD) patients, increases in severity as the disease progresses, and is associated with increased morbidity. We are assessing use of pimava...

Daryl DeKarske , MPH;

Bruce Coate , MPH;

James C. Norton , PhD;

Michael Guskey , PharmD;

Gustavo Alva , MD, DFAAPA;

Jason Aldred , MD, FAAN;

Marc Cantillon , MD;

11/22/2019